Earnings Beat: Guardian Pharmacy Services, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Guardian Pharmacy Services, Inc. (NYSE:GRDN) recently surpassed analyst forecasts with strong Q2 results, reporting revenues of US$352m (3.3% above estimates) and EPS of US$0.34 (51% ahead of expectations). Following these results, analysts have updated their models, maintaining revenue estimates for 2026 at US$1.44b but increasing EPS expectations to US$1.23, an 18% climb. Despite the improved earnings outlook, the consensus price target remains unchanged at US$48.83, and the company's projected revenue decline of 3.0% by 2026 is expected to lag the industry's 5.0% annual growth forecast.